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Abstract 
White spot syndrome virus (WSSV) is a highly pathogenic and prevalent virus affecting shrimp 
culture worldwide including Iran. In the present study, a pair of primers was designed 
according to the sequence of VP 28 gene of WSSV in the GenBank. VP28 gene from an Iranian 
WSSV isolate (IrVP28) was cloned, sequenced and expressed in Escherichia coli BL21(DE3) 
strain in order to produce VP28 protein using PET28a expression vector. The expression 
resulted in a protein of about 30kDa, which was purified under denaturing conditions, resulting 
in a highly purified final IrVP28 preparation. The obtained recombinant protein can be used in 
several biotechnology applications, such as production of monoclonal antibodies which could 
be used in development of diagnostic tools and potential oral vaccination of shrimp with 
vaccines consisting of VP28 proteins. 
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Introduction 
WSSV is one of the most serious viral 
diseases affecting cultured shrimp 
worldwide (Lo et al., 1996; Flegel, 2007). 
This lethal virus causes formation of white 
spots in exoskeleton under carapace and can 
infect not only penaeid shrimps, but also 
other marine and freshwater crustaceans 
(Lo et al., 1996). The first outbreak of 
WSSV began to occur in Asia during mid-
1990s and later in Americas in late 1990s, 
causing massive mortality rates in shrimp 
farms (Lightner, 2003). WSSV has been 
isolated from different geographic regions, 
such as Korea, Thailand, China and 
Americas (Lightner, 2003). Although the 
WSSV disease had been detected in Iran 
since 2002 (OIE, 2003), no report 
concerning characterization of Iranian 
isolates is found in the literature. Since 
2002, WSSV outbreaks have been reported 
in southern Iran, causing losses estimated at 
several million dollars per year (OIE, 2003; 
Afsharnasab et al., 2007). 
     WSSV consists of a large enveloped 
virus, ovoid to baciliform in shape, 
containing a circular double-stranded DNA 
genome of 300 kb with approximately 180 
putative open reading frames (Marks et al., 
2004). Based on its unique genetic 
information and morphological features, 
WSSV represents a novel genus of DNA 
viruses, Whispovirus, belonging to the 
family Nimaviridae (van Hulten et al., 
2001a). This virus contains five major 
structural proteins, located in the viral 
envelope (VP19 and VP28) and in the 
nucleocapsid (VP15, VP24 and VP26). 
VP28 (~30kDa) is the most abundant 
structural protein present in the envelope 
(Tang et al., 2007) and shows no similarity 
with other known proteins, (Robalino et al., 
2006). This envelope protein was suggested 
to bind to shrimp cells, playing a crucial role 
in the viral penetration (Yi et al., 2004). 
Moreover, it has been shown that anti-VP28 
antibodies can neutralize the virus and 
block the viral infection (Yi et al., 2004). 
Juvenile shrimps, Penaeus (Metapenaeus) 
japonicus were fed with commercial feeds 
that were mixed with recombinant VP28, a 
structural protein antigen of WSSV for a 
period of 14 days. The immune response of 
shrimp during oral administration of 
medicated feed was determined by 
expression analysis of fortilin, a gene that is 
involved in the antiviral response. There 
was a significant increase in the level of 
expression of fortilin both in gut and gills in 
the fed group during feeding (Caipang and 
Fagutao, 2013). 
      However, the mechanisms of virus entry 
into cells are still unknown but, 
identification of host cellular proteins 
interacting with WSSV will help in 
unraveling the repertoire of host proteins 
involved in WSSV infection (Biradar et al., 
2013).  
     The highly conserved nature of WSSV 
structural proteins enables the production of 
recombinant proteins for different 
applications, such as production of poly and 
monoclonal antibodies that can be 
employed in immunodiagnostic assays, like 
immunochromatographic kits (Wang and 
Zhan, 2006). Since currently there is no 
effective treatment for shrimp viral 
diseases, and vaccines cannot be developed 
and used in shrimp aquaculture due to lack 
of adaptive immune system in crustaceans, 
rapid diagnosis is one of the most valid 
strategies to curtail WSSV infection (Liu et 
al., 2009). Moreover, structural 
recombinant WSSV proteins can be used in 
order to understand the mechanisms of 
WSSV infection, morphogenesis and 
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interaction with host molecules (Tang et al., 
2007). With this knowledge immune 
responses of host cells advance to next 
levels, in this regard a fragment of the VP28 
coding sequence from a Brazilian WSSV 
isolate (BrVP28) was cloned, sequenced 
and expressed in E. coli BL21(DE3) pLysS 
strain in order to produce the VP28 
carboxyl-terminal hydrophilic region 
(Braunig et al., 2011). 
      In the present study, VP28 gene 
(IrVP28) from Iranian WSSV isolate was 
cloned in order to characterize and produce 
its protein. We amplified VP28 gene and 
cloned it in PTZ57R/T vector to aim this 
purpose: first, having a storehouse for gene 
amplification; second, checking enzymatic 
site on designated primers; third, just having 
digested the gene for ligation phase. 
 
Materials and Methods 
The WSSV-infected shrimps 
(Fenneropenaeus indicus) were obtained 
from shrimp farms in Abadan, southern 
Iran. Genomic DNA was extracted from the 
infected shrimp cephalothoraxes by 
standard phenol-chloroform extraction 
method (Green et al., 2012). Then genome 
purification and quantification were 
estimated using a spectrophotometer and 
also DNA concentration was assessed by 
agarose gel electrophoresis and NanoDrop 
system. 
      Two pairs specific primers were 
designed based on the VP28 sequence from 
an Indian WSSV isolate (GenBank: 
DQ681069), including 5̕-
ATAGGATCCAGGATGGATCTTTCTTT
CACT-3̕ as forward and 5̕-
ATAGAATTCTTACTCGGTCTCAGTGC
CA-3̕ as reverse for the amplification of 615 
bp amplicon of the vp28 gene. The 
underlined nucleotides in the sense strand 
indicate the location of a BamHI site, while 
those in the antisense strand indicated the 
location of aEcoRI site. PCR amplification 
was performed in a final volume of 25 μl 
containing 1x reaction buffer, 0.2 mM of a 
dNTP mixture, 1.5 mM MgCl2, 1 μM of 
each primer, 1 unit of Taq DNA Polymerase 
(Sinagene) and 20 ng of DNA template. 
PCR reaction was conducted with an initial 
denaturation step at 95°C for 3 min, 
followed by 35 cycles of denaturation at 
95°C for 1 min, annealing at 57°C for 1 min 
and extension at 72°C for 1 min, with a final 
extension step at 72°C for 25 min. The 
amplification products were resolved in 1% 
agarose gel, stained with gel red, visualized 
in a transilluminator and digitally recorded. 
Subsequently, PCR products were cloned 
into PTZ57R/T vector (Fermentas) and the 
recombinant plasmid (PTZ57R/T-IrVP28) 
was used to transform Escherichia coli 
DH5α competent cells. The transformed 
cells were selected on amplicillin-
containing LB plates (100 μg mL-1) and 
screened by colony PCR using the above 
mentioned primers. The PTZ57R/T-IrVP28 
plasmid was digested (Fermentas Fast 
Digestion Enzyme) and the excised 
fragment IrVP28 was cloned into pET-28a 
vector (Novagen) at the BamHI and EcoRI 
sites, generating plasmid pET-28a-IrVP28. 
The fragment was inserted downstream and 
in-frame with a coding sequence 
corresponding to a histidine tag, and was 
further sequenced in both directions.  
      With the aim to produce recombinant 
IrVP28, the pET-28a-IrVP28 plasmid was 
used to transform E. coli BL21(DE3) strain. 
Single positive colonies were picked and 
cultured overnight at 37 °C in 10 ml of LB 
medium supplied with kanamycin             
(50μgml-1). One aliquot of 5 ml of the 
overnight culture were inoculated into 10 
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ml of the same medium and were grown at 
37°C until OD600nm ~0.5–0.7. Cultures 
were then induced with 1 mM IPTG 
(isopropyl-β-d-thiogalactopyranoside) and 
incubated at 37°C for further 5 h. All 
induced cells from each hour post induction 
as well as non induced cells were pelleted at 
4000 x g for 15 min and stored at –20°C for 
next uses. The pellets lysed in sample buffer 
and the suspension was boiled for 10 min 
and analysed on 10% SDS- PAGE. Protein 
purification of the cell lysate was carried out 
using a Qiagen Ni-NTA column of 
chromatography against His-tag with a 
denaturation purification protocol as 
specified by the manufacturer (QIAGEN, 
USA). The purified protein was analysed on 
SDS-PAGE. Protein bands were visualized 
by staining with Coomassie Brilliant Blue. 
 
Results 
The concentration of WSSV DNA was 
1500 ng/μl which was used as a template for 
vp28 gene amplification. The PCR product 
was analysed on 1% agarose gel and the size 
of PCR product was in accordance with part 
of VP28 gene size in gene bank and was 615 
bp (Fig. 1). After colony PCR from 5 
random selected DH5α white colonies; the 
PCR product was analysed on 1% agarose 
gel shown 2 colonies bearing the interest 
gene (Fig. 2). Then, the VP28 gene was 
cloned in PET28a vector and ligation 
product transformed in BL21 (DE3) which 


































Figure 1: the part of VP28 gene size which 
amplified on 1% agarose gel. 
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Figure 2: colony PCR from random selected 
DH5α white colonies on 1% agarose gel. 
Lan 1 & 2: positive colonies, Lan 3, 4 &5: negative 





Figure 3: colony PCR from 3 random selected 
colonies on 1% agarose gel. 
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The sequencing result also showed that 
Iranian WSSV VP28 gene sequence was 
completely similar to other VP28 sequences 
published in gene bank. According to the 
sequencing results, it was clear that the start 
codon of VP28 gene was in frame with N-
terminal of the His6-tag of the PET28a 
vector (data not shown). The VP28 was 
expressed as recombinant protein with 
His6-tag at its amino termini in E. coli. 
expected band of 30 KDa was detected on 
the SDS-PAGE in different duration of the 
induction (Fig. 4). 
 
Figure 4: VP28 gene expression on SDS-PAGE. 
Lan 1: transformed BL21 (DE3) with recombinant PET28a vector before adding IPTG, Lan 2: 1 hour after adding IPTG, Lan 
3: 2 hour after adding IPTG, Lan 4: 3 hour after adding IPTG, Lan 5: 4 hour after adding IPTG, Lan 6: 5 hour after adding 
IPTG, Lan 7: Fermentas protein Ladder 
 
As shown in Fig. 5 the expressed protein 
was not detected in supernatant that means 
it might be in insoluble form. The results 
showed that IPTG with concentration of 1 
mM and 5 h of incubation under shaking 
condition after induction was optimum for 
expression of the protein. After expression 
and purification of recombinant VP28, the 
product was analysed on SDS-PAGE as 
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Figure 5: VP28 protein expression on SDS-
PAGE. 
 (A) Lan 1: transformed BL21 (DE3) with 
recombinant PET28a after adding IPTG, Lan 2: 
protein expression in BL21 (DE3) with PET28a 
vector, Lan M: Fermentas protein Ladder, (B) Lan 1: 
purified protein, Lan 2: Media for soluble protein 
 
Discussion 
In this study, we have successfully cloned a 
novel gene (VP28) from WSSV by using a 
vectors library. The gene possibly encoded 
a structural protein. In order to locate VP28 
gene, the gene was expressed in E. coli and 
the purified VP28 protein. While our studies 
were in progress, homology searches with 
the VP28 protein in GenBank using fasta 
and blasta showed that vp28 was homolog 
with Indian VP28 (GenBank: DQ681069; 
DQ013881; DQ013882; DQ013883). 
     Some studies reported purification of 
recombinant proteins from acrylamide gel 
slab (Chaivisuthangkura et al., 2004), but 
the histidine tagged protein purification 
protocol used in the present work was 
relatively simpler and provided a pure 
preparation without bacterial protein 
contaminants. Using this method of 
purification, a final protein yield, between 
128 to 241 μg/ml, was achieved. 
     VP28 protein was reported to play a key 
role in the initial steps of systemic infection 
of WSSV in shrimp (van Hulten et al., 
2001a, b; Leu et al., 2013). The 
recombinant VP28 protein expressed in E. 
coli has been successfully utilized to 
‘vaccinate’ shrimp (Namikoshi et al., 
2004). Although it is effective using E. coli 
to produce recombinant proteins, the 
expressed proteins are usually in form of 
inclusion bodies that must be solubilized 
and renatured before they can become 
biologically active. Therefore, the use of 
rVP28 to produce monoclonal and 
polyclonal antibodies targeting rVP28 for 
diagnosis was suggested (Anil et al., 2002; 
Chaivisuthangkura et al., 2004; Makesh et 
al., 2006) and recently new projects are 
advanced (Fu et al., 2010; Du et al., 2013). 
      In vivo neutralization experiments with 
neutralizing antibodies have been used for 
many viruses and have led to passive 
immunization strategies for WSSV (van 
Hulten et al., 2001b; Kim et al., 2004; Wu 
et al., 2005; Musthaq et al., 2006; Robalino 
et al., 2006; Natividad et al., 2007). 
Recombinant VP28 is wildly used to control 
WSS although the protection mechanism is 
unclear and its efficacy varies. One possible 
mechanism of rVP28 is that it binds to 
shrimp VP28 binding protein, preventing 
the binding of WSSV to cells (Xu et al., 
2006). 
     Another possibility suggested by many 
studies is that rVP28 stimulates shrimp 
immunity or acts as a vaccine (Bright Singh 
et al., 2005; Du et al., 2006; Vaseeharan et 
al., 2006; Witteveldt et al., 2006; Jha et al., 
2007; Rout et al., 2007; Mavichak et al., 
2009). Although, the evidence that rVP28 
increases the shrimp survival rate against 
WSSV, the protection ability of rVP28 
varies and seems to rely on the amount of 
proteins received (Jha et al., 2006). 
     Cloning of the vp28 gene in the pET-28a 
expression system led to the expression of a 
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protein with approximately 30 kDa MW. In 
this system, an additional bp from the vector 
corresponding to the His-6tag was also 
coexpressed with the complete VP28 
protein. Expression was standardized with 
different concentrations of IPTG and 
different time durations after induction. 
Purification was achieved under 
denaturation conditions (Fig. 5). Therefore, 
in this study we attempt to produce IrVP28 
isolated WSSV from Iran to survey its 
antigenicity to use in serological diagnosis 
and oral vaccines in future. In this case a 
new generation of oral vaccine is suggested 
(Kulkarni et al., 2013) 
      Recombinant VP28 protein production 
from Khozestan Province isolated from 
WSSV by PET28a vector is possible. 
According to the importance of this protein 
and for future studies, the possibility of this 
protein production is available. Our results 
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